Le Lézard
Classified in: Environment, Health, Science and technology
Subject: ACC

Desert Control releases its Q4 2023 Report and Year-to-date Company Update


2023 was marked by operational milestones and strategic restructuring, increasing the balance sheet by more than NOK 100M of added liquidity. The start of 2024 marks the launch of the first commercial LNC roll-out in the United States with Limoneira, and the licensed operator model has secured the first partner-driven commercial project in the Middle East.

SANDNES, Norway, Feb. 22, 2024 /PRNewswire/ -- Q4 2023 and Year-to-Date 2024 Highlights

Corporate

United States

Middle East

Financial Highlights Fourth Quarter 2023

[fourth quarter 2022 in brackets]

Financial Highlights Full Year 2023

[full year 2022 in brackets]

Cautionary Note:

Disclaimer related to forward-looking statements.

This release contains forward-looking information and statements relating to the business, performance, and items that may be interpreted to impact the results of Desert Control and/or the industry and markets in which Desert Control operates.

Forward-looking statements are statements that are not historical facts and may be identified by words such as "aims", "anticipates", "believes", "estimates", "expects", "foresees", "intends", "plans", "predicts", "projects", "targets", and similar expressions. Such forward-looking statements are based on current expectations, estimates, and projections, reflect current views concerning future events, and are subject to risks, uncertainties, and assumptions, and may be subject to change without notice. Forward-looking statements are not guaranteeing any future performance, and risks, uncertainties, and other important factors could cause the actual business, performance, results, or the industry and markets in which Desert Control operates in, to differ materially from the statements expressed or implied in this release by such forward-looking statements.

No representation is made that any of these forward-looking statements or forecasts will come to pass or that any forecasted performance, capacities, or results will be achieved, and you are cautioned not to place any undue reliance on any forward-looking statements.

Q4 Report 2023

The information enclosed is subject to the disclosure requirements pursuant to sections 5-12 in the Norwegian Securities Trading Act.

For more information, please contact:

Ole Kristian Sivertsen
President and Group CEO
Email: [email protected] 
Mobile (NOR): +47 957 77 777
Mobile (USA): +1 650 643 6136
Mobile (UAE): +971 52 521 7049

Leonard Chaparian
Chief Financial Officer
Email: [email protected]
Mobile (NOR): +47 90 66 55 40

The following files are available for download:

https://mb.cision.com/Main/22706/3929705/2620779.pdf

DesertControl_Q4_2023_Report

 

SOURCE Desert Control AS


These press releases may also interest you

at 09:13
Methodist Le Bonheur Healthcare announced Methodist University Hospital earned top recognition by Money magazine as one of the Best U.S. Hospitals for Cardiac Care. The Memphis-based healthcare system's academic flagship landed 15th out of 75 and is...

at 09:06
Avicenna.AI, a leading medical imaging AI company, has received Medical Device Regulation (MDR) certificate for five of its algorithms from certification body BSI Medical Devices. This development means the company's product portfolio is fully...

at 09:03
Insmed Incorporated , a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that additional positive results from the ASPEN...

at 09:00
In March 2024, dairy cows in Texas were found to be infected with highly pathogenic avian flu, or H5N1 bird flu, in the first known case of the virus spreading to cattle. Since then, H5N1 has been found in about 200 animals?and 3 people?across 12...

at 09:00
Emmaus Life Sciences, Inc. , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2023....

at 09:00
Global health company The Cigna Group will release its second quarter 2024 financial results on Thursday, August 1, 2024, and will host a conference call the same day....



News published on and distributed by: